Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Perfectha Finelines Lidocaine
- Development stage
- Unknown
- Lead developer
- Sinclair
- Administration
- Intradermal
01
Overview
Perfectha Finelines Lidocaine is a bi-phasic, BDDE cross-linked hyaluronic acid (HA) injectable dermal filler at a concentration of 20 mg/mL, formulated with 0.3% (w/w) lidocaine hydrochloride as a local anesthetic to reduce injection discomfort. Developed and marketed by Sinclair Pharmaceuticals (a subsidiary of Huadong Medicine) and manufactured by Laboratory ObvieLine, the product utilizes proprietary E-brid technology to create a resorbable gel implant. It is indicated for the treatment of superficial facial wrinkles, including tear trough deformity, periorbital wrinkles (crow's feet), perioral wrinkles, and marionette lines. Classified as a Class III medical device in the European Union, it is injected into the superficial dermis to provide structural augmentation and volume to the extracellular matrix.
- Brand names
- Perfectha Finelines LidocainePerfectha
- Other names
- Perfectha Finelines with Lidocaine
02
Targets
NaV (Voltage-gated sodium channels)CD44 (CD44 antigen)
Beyond the preview
Go deeper on Perfectha Finelines Lidocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Perfectha Finelines Lidocaine.